BIRC5 and neoplasm: YM155 is a selective small molecule inhibitor of survivin transcription that exhibits potent antitumor activity by inducing apoptosis and autophagy in various types of cancer, as well as enhancing the anti-tumour and anti-angiogenic effects of chemotherapy drugs such as cisplatin [63,64,65].